Do immunosuppressants really work as maintenance therapy after the achievement of remission of severe ulcerative colitis?
Naganuma
Makoto
M
Hibi
Toshifumi
T
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects; D001379:Azathioprine / Q000008:administration & dosage* / Q000009:adverse effects; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D015122:Mercaptopurine / Q000008:administration & dosage / Q000009:adverse effects; D055502:Secondary Prevention; D012460:Sulfasalazine / Q000008:administration & dosage / Q000009:adverse effects
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D012460:Sulfasalazine; D015122:Mercaptopurine; D001379:Azathioprine